prikaz prve stranice dokumenta Uloga receptora CD 44 i CD 168 (RHAMM) u progresiji karcinoma endometrija
No public access
doctoral thesis
Uloga receptora CD 44 i CD 168 (RHAMM) u progresiji karcinoma endometrija
doktorski rad
Rijeka: University of Rijeka, Faculty of Medicine, 2012. urn:nbn:hr:188:426938

University of Rijeka
Faculty of Medicine
Department of Gynaecology and Obstetrics

Cite this document

Klarić, M. (2012). Uloga receptora CD 44 i CD 168 (RHAMM) u progresiji karcinoma endometrija : doktorski rad (Doctoral thesis). Retrieved from https://urn.nsk.hr/urn:nbn:hr:188:426938

Klarić, Marko. "Uloga receptora CD 44 i CD 168 (RHAMM) u progresiji karcinoma endometrija : doktorski rad." Doctoral thesis, University of Rijeka, Faculty of Medicine, 2012. https://urn.nsk.hr/urn:nbn:hr:188:426938

Klarić, Marko. "Uloga receptora CD 44 i CD 168 (RHAMM) u progresiji karcinoma endometrija : doktorski rad." Doctoral thesis, University of Rijeka, Faculty of Medicine, 2012. https://urn.nsk.hr/urn:nbn:hr:188:426938

Klarić, M. (2012). 'Uloga receptora CD 44 i CD 168 (RHAMM) u progresiji karcinoma endometrija : doktorski rad', Doctoral thesis, University of Rijeka, Faculty of Medicine, accessed 07 October 2022, https://urn.nsk.hr/urn:nbn:hr:188:426938

Klarić M. Uloga receptora CD 44 i CD 168 (RHAMM) u progresiji karcinoma endometrija : doktorski rad [Doctoral thesis]. Rijeka: University of Rijeka, Faculty of Medicine; 2012 [cited 2022 October 07] Available at: https://urn.nsk.hr/urn:nbn:hr:188:426938

M. Klarić, "Uloga receptora CD 44 i CD 168 (RHAMM) u progresiji karcinoma endometrija : doktorski rad", Doctoral thesis, University of Rijeka, Faculty of Medicine, Rijeka, 2012. Available at: https://urn.nsk.hr/urn:nbn:hr:188:426938

Please login to the repository to save this object to your list.